Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
1.79
Dollar change
-0.09
Percentage change
-4.52
%
IndexRUT P/E- EPS (ttm)-0.56 Insider Own28.01% Shs Outstand127.92M Perf Week-13.29%
Market Cap499.95M Forward P/E- EPS next Y-0.42 Insider Trans11.79% Shs Float92.13M Perf Month-13.29%
Income-45.61M PEG- EPS next Q-0.15 Inst Own43.17% Short Float11.53% Perf Quarter-23.29%
Sales0.00M P/S- EPS this Y-2.23% Inst Trans9.56% Short Ratio15.48 Perf Half Y-34.25%
Book/sh-7.66 P/B- EPS next Y28.54% ROA-9.84% Short Interest10.62M Perf Year1.41%
Cash/sh1.46 P/C1.23 EPS next 5Y- ROE- 52W Range1.18 - 4.44 Perf YTD0.84%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-59.57% Beta1.41
Dividend TTM- Quick Ratio17.09 Sales past 5Y0.00% Gross Margin- 52W Low52.12% ATR (14)0.19
Dividend Ex-Date- Current Ratio17.09 EPS Y/Y TTM4.19% Oper. Margin- RSI (14)45.50 Volatility9.80% 11.65%
Employees163 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom2.00 Target Price4.80
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q20.36% Payout- Rel Volume0.73 Prev Close1.88
Sales Surprise- EPS Surprise-9.72% Sales Q/Q- EarningsNov 12 BMO Avg Volume686.14K Price1.79
SMA20-4.58% SMA50-2.25% SMA200-18.73% Trades Volume499,118 Change-4.52%
Date Action Analyst Rating Change Price Target Change
Sep-30-24Initiated JP Morgan Neutral
Sep-10-24Initiated Guggenheim Buy $6
Mar-07-24Resumed Morgan Stanley Equal-Weight $3
Jan-02-24Downgrade BofA Securities Buy → Neutral
Jul-25-23Initiated BTIG Research Buy $16
Dec-21-22Initiated Jefferies Buy $15
Nov-10-22Initiated Morgan Stanley Equal-Weight $13
Oct-18-22Initiated UBS Buy $18
Oct-14-22Initiated Citigroup Buy $16
Sep-23-22Initiated BofA Securities Buy $14
Nov-26-24 07:30AM
Nov-12-24 07:30AM
Nov-05-24 07:30AM
Oct-22-24 07:02PM
Oct-14-24 07:30AM
07:30AM Loading…
Oct-09-24 07:30AM
Sep-04-24 01:33PM
Sep-03-24 07:30AM
Aug-27-24 07:30AM
Aug-09-24 07:00AM
Jun-27-24 05:52AM
Jun-26-24 02:10PM
Jun-17-24 07:00AM
Jun-11-24 09:35PM
07:40AM
04:15PM Loading…
Jun-10-24 04:15PM
07:32AM
06:30AM
May-29-24 07:00AM
May-21-24 07:00AM
May-10-24 03:43PM
01:54PM
07:48AM
07:00AM
Mar-25-24 06:05AM
Mar-21-24 07:49PM
Feb-29-24 04:05PM
Dec-29-23 08:22AM
Dec-13-23 09:55AM
Nov-30-23 06:05AM
06:40AM Loading…
Nov-24-23 06:40AM
Nov-21-23 06:05AM
Nov-17-23 01:38PM
Nov-16-23 09:35AM
Nov-14-23 07:04AM
06:05AM
Nov-13-23 05:02PM
Oct-30-23 04:12PM
Oct-17-23 09:35AM
Oct-16-23 02:50PM
Oct-12-23 03:05PM
Sep-06-23 12:14PM
Sep-05-23 06:05AM
Aug-31-23 10:33AM
Aug-29-23 01:16PM
Aug-11-23 02:21PM
Aug-10-23 04:10PM
Jul-18-23 06:05AM
Jul-17-23 06:05AM
Jun-13-23 12:05PM
Jun-01-23 04:05PM
May-11-23 04:01PM
May-04-23 06:05AM
Apr-25-23 02:00PM
Mar-28-23 04:12PM
Mar-03-23 06:05AM
Jan-11-23 07:48AM
Jan-10-23 04:05PM
Dec-27-22 11:05AM
08:46AM
Dec-22-22 06:05AM
Nov-16-22 11:22AM
Nov-14-22 06:05AM
Nov-11-22 04:05PM
Nov-03-22 06:05AM
Oct-14-22 12:00PM
Sep-23-22 06:15AM
Sep-08-22 06:05AM
Aug-31-22 06:05AM
Aug-11-22 05:30PM
10:01AM
Jul-20-22 08:00AM
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weber Darin J.Chief Regulatory OfficerSep 19 '24Sale2.5016,41241,030103,480Sep 20 04:44 PM
DARIN J WEBEROfficerSep 19 '24Proposed Sale2.3916,41239,225Sep 19 04:27 PM
Weber Darin J.Chief Regulatory OfficerJul 26 '24Sale2.508262,065119,892Jul 29 04:02 PM
Control Empresarial de CapitalAdd'l Rep. Persons-see Ex.99-1Jun 11 '24Buy2.428,264,46219,999,99871,560,107Jun 25 04:06 PM
Weber Darin J.Chief Regulatory OfficerJun 18 '24Sale2.8217,23848,616120,718Jun 20 04:03 PM
Legorreta Pablo G.DirectorJun 13 '24Buy2.4222,617,90954,735,34022,617,909Jun 14 04:05 PM
Weber Darin J.Chief Regulatory OfficerMay 20 '24Sale4.0817,23870,386137,956May 22 07:22 AM
Control Empresarial de CapitalAdd'l Rep. Persons-see Ex.99-1Mar 13 '24Buy1.5050,00075,09063,168,645May 16 08:22 PM
Control Empresarial de CapitalAdd'l Rep. Persons-see Ex.99-1Mar 14 '24Buy1.3650,00067,92563,218,645May 16 08:22 PM
Control Empresarial de CapitalAdd'l Rep. Persons-see Ex.99-1Mar 20 '24Buy1.4033,00046,11163,251,645May 16 08:22 PM
Control Empresarial de CapitalAdd'l Rep. Persons-see Ex.99-1Mar 25 '24Buy1.4330,00042,95463,295,645May 16 08:22 PM
Control Empresarial de CapitalAdd'l Rep. Persons-see Ex.99-1Mar 22 '24Buy1.4014,00019,58663,265,645May 16 08:22 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 22 '24Sale2.5116,43841,315155,194Apr 23 04:05 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 18 '24Sale2.548002,028171,632Apr 23 04:05 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 16 '24Sale2.5017,23843,095172,432Apr 17 06:57 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 12 '24Sale1.7384,103145,498189,670Apr 16 04:54 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 01 '24Sale1.69300507273,773Apr 16 04:54 PM